dorsaVi (DVL.AX) Aktie Kurs

dorsaVi Ltd is primarily active in the healthcare and sports industries.

Some of the main competitors of dorsaVi Ltd in the market include companies such as Vicon Motion Systems Ltd, Xsens Technologies B.V., and Optitrack.

dorsaVi Ltd, a renowned company in the healthcare industry, has an impressive history and background. Founded in 2000 and headquartered in Melbourne, Australia, dorsaVi specializes in wearable sensor technology. The company aims to improve the detection, prevention, and management of musculoskeletal and neurological conditions. dorsaVi's cutting-edge products, such as the ViMove system, offer accurate and objective movement analysis, helping healthcare professionals and patients optimize treatment plans. With a focus on innovation and research, dorsaVi has gained recognition worldwide, collaborating with leading institutions and healthcare providers. By combining technology and healthcare expertise, dorsaVi Ltd continues to drive advancements in patient care and movement analysis.

dorsaVi Ltd is a leading company that has achieved significant milestones in its operations. Some notable achievements include the successful launch of its innovative ViMove technology, which provides accurate and objective motion analysis for healthcare professionals and athletes. The company's partnership with global corporations has also strengthened its market presence and expanded its reach. Additionally, dorsaVi Ltd has received various industry accolades and awards for its groundbreaking solutions and contributions to the healthcare sector. With continuous innovation and a strong focus on enhancing human movement assessment, dorsaVi Ltd continues to cement its position as a pioneering force in the industry.

dorsaVi Ltd primarily operates and serves in several countries and regions worldwide. Some of the key geographical areas where the company is present include Australia, Singapore, United Kingdom, United States, and New Zealand.

dorsaVi Ltd represents transparency, innovation, and a commitment to improving human movement and performance. With a corporate philosophy centered around precision and evidence-based solutions, dorsaVi develops wearable sensor technology that provides valuable insights into biomechanics and neuromuscular control. By combining their expertise in sports science, physiotherapy, and engineering, the company aims to revolutionize the way individuals assess, manage, and enhance their physical abilities. The focus on accurate data collection and analysis enables dorsaVi to empower athletes, healthcare professionals, and everyday individuals with actionable information for injury prevention, performance optimization, and personalized treatment plans.

7 analytikere vurderer i øjeblikket dorsaVi-aktien: 0 anbefaler køb, 3 hold og 4 salg.

dorsaVi Analytikerens Kursmål 2026

Omregnet til den aktuelle valutakurs handles dorsaVi-aktien til 0,01 EUR (0,02 AUD).

dorsaVi-aktien (DVL.AX) er noteret på 1 børser, herunder: ASX (DVL.AX).

dorsaVi Ltd is a technology and healthcare company based in Australia with offices worldwide. The company offers a variety of products and services that contribute to improving health, fitness, and performance. The main business of dorsaVi is the development and marketing of solutions for motion analysis and monitoring. The core areas of work are clinical application, sports performance enhancement, and occupational health and safety. The company offers a range of products and services that focus on the goal of optimizing movement. One key component of dorsaVi's solutions is wireless sensors that are attached to various parts of the body. These sensors measure muscle activity, movement direction, and force exertion, among other things. The data collected is analyzed and visualized using appropriate software. The software platform provides differentiated analytics options. As an important part of dorsaVi's service offering, web-based solutions are also available for different target groups. From professional athletes to patients requiring rapid and accurate rehabilitation, the company provides tailored online solutions that are customized to individual needs. However, dorsaVi's solutions are not therapy but exclusively provide effective diagnostics and, accordingly, an objective assessment of therapy progress. One application area for dorsaVi technology, for example, is orthopedic rehabilitation facilities, where the technology supports patients before or after orthopedic surgeries. Additionally, the technology is also used in performance enhancement for professional athletes. The company has specialized in various body areas to offer targeted solutions for specific problems. Whether it is the back, shoulder, knee, or hip area, the portfolio includes numerous products for different issues. Another important business area for dorsaVi is occupational safety and ergonomics. Companies can use motion sensors to monitor their employees' work environment, identifying and eliminating potential risks. The goal is to make workplaces safer and more productive and thus protect employees in the long run. Innovative thinking and a solid value chain make dorsaVi's products and services unique in their outcomes. With a combination of state-of-the-art sensor technology, user-friendly cloud software, and sound movement research, the company has established a leading position in the motion analysis market. dorsaVi's goal is to continuously improve its solutions and thereby maximize the success of its customers.

-omsætningen for dorsaVi er 1,00 Mio. AUD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

-overskuddet for dorsaVi er -8,52 Mio. AUD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for dorsaVi er i øjeblikket -3,03. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af dorsaVi-aktien.

Pris-til-salgs-forholdet (P/S) for dorsaVi er i øjeblikket 25,71. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for dorsaVi-aktien.

AlleAktien-kvalitetsscore for dorsaVi er 2/10.

ISIN for dorsaVi er AU000000DVL0. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

Tickeren for dorsaVi er DVL.AX. Tickersymbolet bruges til at handle dorsaVi-aktier på børsen.